Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Medical Genetics

Biology & Differential Diagnosis: Distinguishing Aceruloplasminemia

At a Glance

Aceruloplasminemia is an inherited CP-gene disorder in which missing ceruloplasmin traps iron in the liver, brain, and pancreas. This can cause low blood iron despite iron overload, so CP genetic testing and brain or liver MRI help distinguish it from Wilson disease and hemochromatosis.

The biological cause of aceruloplasminemia lies in a single protein that fails to do its job. To understand this condition, it helps to look at the genetics behind it.

The Missing Protein

Your body uses a gene called CP to create a protein called ceruloplasmin. In aceruloplasminemia, you have inherited two mutated copies of this gene (one from each parent), a pattern known as autosomal recessive inheritance [1][2]. Because it is recessive, siblings typically have a 25% chance of also being affected, a 50% chance of being carriers, and a 25% chance of being unaffected. Genetic counseling is highly recommended to explain testing for your family.

These mutations prevent your body from making functional ceruloplasmin. Normally, this protein acts as a ferroxidase—an enzyme that oxidizes iron so it can exit your storage cells via a transporter called ferroportin, allowing it to bind to transferrin and travel through the blood [3][4].

  • The Trap: Without this ferroxidase activity, iron mobilization is impaired. Iron is pulled into your organs but cannot be effectively exported [5].
  • The Starvation: Because the iron is trapped in your liver, brain, and pancreas, your blood does not have enough iron binding to transferrin to build healthy red blood cells [3]. This is why you may have microcytic anemia (small red blood cells) even though your body is actually overloaded with iron [1].

Why Doctors Often Misdiagnose This

Because aceruloplasminemia is so rare, many doctors have never seen a case. Its symptoms overlap with more common diseases, often leading to a long diagnostic odyssey [6][7].

  • Mistaken for Iron Deficiency: Because blood tests show low serum iron, doctors may prescribe iron supplements. However, unless you have a documented separate nutritional deficiency, these can be harmful because they add more iron to organs that are already struggling with overload [8][9]. Do not start or stop iron supplements without specialist review.
  • Mistaken for Wilson’s Disease: Both conditions involve low levels of ceruloplasmin. However, Wilson’s is a copper disorder caused by ATP7B mutations, while aceruloplasminemia is an iron disorder [10][11].
  • Mistaken for Type 2 Diabetes: Because diabetes is often an early symptom, doctors may initially treat it as standard adult-onset diabetes, missing the fact that iron deposits in the pancreas are involved [3].

Distinguishing the Look-Alikes

To confirm aceruloplasminemia, doctors must distinguish it from other conditions that cause iron or copper issues. The table below highlights the typical patterns your medical team looks for (note that overlapping conditions require specialist evaluation and overlapping features do exist):

Feature Aceruloplasminemia Wilson’s Disease Hereditary Hemochromatosis
Primary Metal Iron [3] Copper [10] Iron [12]
Gene Mutation CP [1] ATP7B [10] HFE (most common) [12]
Ceruloplasmin Absent or near zero [13] Often Low (but can be normal) [10] Normal
Iron in Blood Usually Very Low [3] Normal Very High [14]
Brain Iron High (Basal Ganglia, Thalami) [15] Variable (copper accumulates) Usually None
Anemia Common (Microcytic) [1] Uncommon Uncommon

Other Rare Comparisons

Your doctor may also rule out two other specific conditions:

  1. Ferroportin Disease: This can also cause high ferritin and low-normal iron in the blood. However, it typically stores iron in the macrophages/spleen and generally lacks the brain iron accumulation seen in aceruloplasminemia [14][16].
  2. Neuroferritinopathy: This is another NBIA disorder that causes iron in the brain. However, it is caused by a mutation in the FTL gene and typically does not cause the severe systemic iron overload in the liver or the diabetes seen in aceruloplasminemia [17][18].

The most definitive way to tell these apart is through expert clinical assessment, genetic testing, and specific MRI imaging of the brain and liver, which can evaluate where the metal is depositing [19][15].

Common questions in this guide

What causes aceruloplasminemia?
Aceruloplasminemia occurs when a person inherits two altered copies of the CP gene, one from each parent. These changes prevent the body from making working ceruloplasmin, a protein that helps move iron out of storage cells. Iron can then build up in organs while too little iron is available in the blood to make red blood cells.
Why can aceruloplasminemia look like iron-deficiency anemia?
Iron may be trapped in the liver, brain, and pancreas instead of being released into the bloodstream. Blood tests can therefore show low serum iron and small red blood cells even though total body iron is high. Iron supplements should not be started or stopped without a specialist’s advice, especially if a separate deficiency has not been confirmed.
How is aceruloplasminemia different from Wilson disease?
Both conditions can cause a low ceruloplasmin level, but they involve different metals and genes. Aceruloplasminemia is an iron-handling disorder caused by CP mutations, while Wilson disease is a copper-handling disorder caused by ATP7B mutations. Doctors use the full pattern of blood tests, clinical findings, genetic testing, and imaging to tell them apart.
What tests help confirm aceruloplasminemia?
Doctors may check ceruloplasmin, serum iron, transferrin saturation, ferritin, and a CP genetic test. Magnetic resonance imaging of the brain and liver can show where iron has accumulated. Results need expert interpretation because other iron or copper disorders can have overlapping features.
What is the chance that my siblings or children will have aceruloplasminemia?
If both parents carry one altered CP gene copy, each sibling has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of being unaffected. The risk for a patient’s children depends on whether the other biological parent carries a CP mutation. Genetic counseling can help determine appropriate family testing.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What were my specific results for serum iron, transferrin saturation, and ferritin?
  2. 2.Can you confirm if my ceruloplasmin levels were just low or completely undetectable?
  3. 3.Based on my test results, how did you rule out Wilson's disease or other iron-overload conditions like hemochromatosis?
  4. 4.Does my genetic report show a 'homozygous' or 'compound heterozygous' mutation in the CP gene?
  5. 5.Since this condition is autosomal recessive, what are the testing recommendations for my siblings or children?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.

    Vila Cuenca M, Marchi G, Barqué A, et al.

    International journal of molecular sciences 2020; (21(7)) doi:10.3390/ijms21072374.

    PMID: 32235485
  2. 2

    Diagnosis of de novo fetal aceruloplasminemia via whole exome sequencing and fetal umbilical blood ceruloplasmin measurement.

    Jin P, Dai G, Hong J, et al.

    Orphanet journal of rare diseases 2026; (21(1)).

    PMID: 42288881
  3. 3

    Aceruloplasminemia: Waiting for an Efficient Therapy.

    Piperno A, Alessio M

    Frontiers in neuroscience 2018; (12()):903 doi:10.3389/fnins.2018.00903.

    PMID: 30568573
  4. 4

    Does Ceruloplasmin Defend Against Neurodegenerative Diseases?

    Wang B, Wang XP

    Current neuropharmacology 2019; (17(6)):539-549 doi:10.2174/1570159X16666180508113025.

    PMID: 29737252
  5. 5

    Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia.

    Kenawi M, Rouger E, Island ML, et al.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2019; (33(12)):13492-13502 doi:10.1096/fj.201901106R.

    PMID: 31560858
  6. 6

    Diagnosing aceruloplasminemia: navigating through red herrings.

    Kharel Z, Kharel H, Phatak PD

    Annals of hematology 2024; (103(6)):2173-2176 doi:10.1007/s00277-024-05743-7.

    PMID: 38637332
  7. 7

    A novel ceruloplasmin mutation identified in a Chinese patient and clinical spectrum of aceruloplasminemia patients.

    Xu WQ, Ni W, Wang RM, et al.

    Metabolic brain disease 2021; (36(8)):2273-2281 doi:10.1007/s11011-021-00799-0.

    PMID: 34347207
  8. 8

    Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia.

    Pelucchi S, Mariani R, Ravasi G, et al.

    Parkinsonism & related disorders 2018; (51()):36-42 doi:10.1016/j.parkreldis.2018.02.036.

    PMID: 29503155
  9. 9

    Inherited iron overload disorders.

    Piperno A, Pelucchi S, Mariani R

    Translational gastroenterology and hepatology 2020; (5()):25 doi:10.21037/tgh.2019.11.15.

    PMID: 32258529
  10. 10

    Disorders Mimicking Wilson's Disease: Clinical, Biochemical, and Molecular Perspectives for Accurate Differential Diagnosis.

    Antos A, Gromadzka G, Bembenek JP, Litwin T

    Diagnostics (Basel, Switzerland) 2026; (16(9)) doi:10.3390/diagnostics16091342.

    PMID: 42122051
  11. 11

    Classification and differential diagnosis of Wilson's disease.

    Hermann W

    Annals of translational medicine 2019; (7(Suppl 2)):S63 doi:10.21037/atm.2019.02.07.

    PMID: 31179300
  12. 12

    Inherited Disorders of Iron Overload.

    Pantopoulos K

    Frontiers in nutrition 2018; (5()):103 doi:10.3389/fnut.2018.00103.

    PMID: 30420953
  13. 13

    Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment.

    Poli L, Alberici A, Buzzi P, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2017; (38(2)):357-360 doi:10.1007/s10072-016-2756-x.

    PMID: 27817091
  14. 14

    Pathophysiology and classification of iron overload diseases; update 2018.

    Brissot P, Troadec MB, Loréal O, Brissot E

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2019; (26(1)):80-88 doi:10.1016/j.tracli.2018.08.006.

    PMID: 30173950
  15. 15

    Brain iron accumulation on MRI revealing aceruloplasminemia: a rare cause of simultaneous brain and systemic iron overload.

    Touarsa F, Ali Mohamed D, Onka B, et al.

    BJR case reports 2022; (8(5)):20220035 doi:10.1259/bjrcr.20220035.

    PMID: 36211608
  16. 16

    Iron metabolism and related genetic diseases: A cleared land, keeping mysteries.

    Brissot P, Loréal O

    Journal of hepatology 2016; (64(2)):505-515 doi:10.1016/j.jhep.2015.11.009.

    PMID: 26596411
  17. 17

    New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients.

    Vroegindeweij LHP, Langendonk JG, Langeveld M, et al.

    Parkinsonism & related disorders 2017; (36()):33-40 doi:10.1016/j.parkreldis.2016.12.010.

    PMID: 28012953
  18. 18

    Neurodegeneration With Brain Iron Accumulation and Ferroptosis Disorders in Children and Adults: An Imaging Review.

    Mertiri L, Lequin M, Rossi A, et al.

    Journal of neuroimaging : official journal of the American Society of Neuroimaging 2025; (35(6)):e70112 doi:10.1111/jon.70112.

    PMID: 41320772
  19. 19

    [Aceruloplasminemia, a rare condition not to be overlooked].

    Lobbes H, Reynaud Q, Mainbourg S, et al.

    La Revue de medecine interne 2020; (41(11)):769-775 doi:10.1016/j.revmed.2020.06.002.

    PMID: 32682623

This page explains the inherited biology and diagnostic differences of aceruloplasminemia for informational purposes only and does not constitute medical advice. A specialist or genetic counselor should interpret your test results and advise on family testing.

Get notified when new evidence is published on Aceruloplasminemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.